Prolactin-Releasing Effect of a Novel Anti-Dopaminergic Drug, Domperidone, in the Rat
作者:
D. Cocchi,
I. Gil-Ad,
M. Parenti,
E. Stefanini,
V. Locatelli,
E.E. Müller,
期刊:
Neuroendocrinology
(Karger Available online 1980)
卷期:
Volume 30,
issue 2
页码: 65-69
ISSN:0028-3835
年代: 1980
DOI:10.1159/000122977
出版商: S. Karger AG
关键词: Haloperidol;Prolactin;Peripheral dopamine receptors;Domperidone
数据来源: Karger
摘要:
The prolactin (PRL)-releasing effect of domperidone (DOM), a blocker of dopamine receptors which does not cross the blood-brain barrier, was studied in unanesthetized male rats and compared to that of the classic neuroleptic agent haloperidol (HAL). DOM proved to be a potent PRL releaser since striking and long-lasting (120 min) rises in plasma PRL were elicited by 50 and 100 μg/kg of the compound. Comparison with HAL showed that DOM was 5 times as potent as HAL as a PRL releaser (ED250 = 0.084 vs. 0.42 mg/kg, respectively). Apomorphine (APO) fully counteracted the PRL-releasing effect of DOM (0.1 mg/kg i.p.) only at the dose of 3 mg/kg s.c, while the PRL-releasing effect of HAL (0.1 mg/kg i.p.) was blocked by APO at the dose of 1 mg/kg s.c. The effect of DOM (0.1 mg/ kg i.p.) on PRL release was also suppressed by another DA-agonist drug, bromocriptine (5 mg/kg s.c). Evaluation of the affinity of DOM and HAL on [3H]-spiperone binding to striatal and pituitary homogenates showed a slightly higher affinity for DOM than HAL on both tissue. Systemic administration of DOM (50 and 100 μg/kg i.p.) left homo-vanillic acid (HVA) concentrations unchanged in the caudate nucleus while, as expected, HAL (0.5 and 1.0 mg/kg i.p.) induced a striking rise in striatal HVA content. These results indicate that DOM, by acting at the level of ‘peripheral’ DA receptors, is a strong PRL-releasing
点击下载:
PDF
(998KB)
返 回